13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q2 2025 · Filed July 22, 2025 · Accession 0000904454-25-000367
Total Value
$334.1M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $136.4M | 40.83% |
| 2 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $43.9M | 13.14% |
| 3 | Rapport Therapeutics, Inc. | RAPP | 2,498,051 | $28.6M | 8.55% |
| 4 | Legend Biotech Corporation | LEGN | 814,586 | $28.2M | 8.44% |
| 5 | Nanobiotix S.A. | NBTX | 5,623,816 | $25.5M | 7.62% |
| 6 | CVRx, Inc. | CVRX | 4,103,430 | $23.9M | 7.15% |
| 7 | Procept BioRobotics Corporation | PRCT | 357,939 | $20.4M | 6.10% |
| 8 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $8.1M | 2.43% |
| 9 | Xencor, Inc. | XNCR | 748,062 | $6.1M | 1.82% |
| 10 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $4.0M | 1.19% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $3.5M | 1.05% |
| 12 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $1.4M | 0.42% |
| 13 | Rallybio Corporation | RLYB | 3,636,363 | $1.2M | 0.36% |
| 14 | Vor Biopharma, Inc. | VOR | 1,074,658 | $1.1M | 0.34% |
| 15 | Nano-X Imaging Ltd. | NNOX | 158,852 | $830,796 | 0.25% |
| 16 | Standard BioTools Inc | LAB | 311,967 | $371,241 | 0.11% |
| 17 | Lyell Immunopharma Inc. | LYEL | 41,165 | $368,015 | 0.11% |
| 18 | Adicet Bio, Inc. | ACET | 364,472 | $228,014 | 0.07% |
| 19 | BiomX Inc. | PHGE | 96,866 | $42,621 | 0.01% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $26,988 | 0.01% |